BIOMAT Database Logo BIOMAT Database Logo

A Low-Cost SARS-CoV-2 rRBD ELISA to Detect Serostatus in Ecuadorian Population with COVID-19. 2021

Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
1Instituto de Biomedicina, Carrera de Medicina, Universidad Central, Quito, Ecuador.

Laboratory diagnosis of the COVID-19 relies on RT-PCR to amplify specific fragments of SARS-CoV-2 genome. However, serological tests are required to determine the immune response elicited after infection. Here, we analyzed convalescent sera collected from positive individuals by RT-PCR to SARS-CoV-2 (n = 78), Zika (n = 20), dengue (n = 20), chikungunya (n = 54), intestinal parasites (n = 11), and HIV (n = 1), from different areas of Ecuador, with an in-house ELISA using a SARS-CoV-2 receptor binding domain recombinant (rRBD) antigen to detect IgG antibodies elicited by SARS-CoV-2 infection. Of the 78 samples positive for SARS-CoV-2 by RT-PCR, 73 showed high absorbance value compared with the cutoff and five were negative. All tested sera from other infections showed no reactivity. Sensitivity, specificity, positive predictive value, and negative predictive value were 93.6%, 100%, 100%, and 95.4%, respectively. This in-house anti-IgG rRBD ELISA offers an economic and simple alternative to determine IgG immune responses after SARS-CoV-2 infection.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004484 Ecuador A country in western South America, bordering the Pacific Ocean at the equator, between Colombia and Peru. Galapagos Islands
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000087124 COVID-19 Serological Testing Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence antibodies specific to SARS-COV-2 or its antigens. COVID-19 Antibody Testing,COVID-19 Serodiagnosis,COVID19 Antibody Testing,COVID19 Serodiagnosis,COVID19 Serological Testing,SARS-COV-2 Antigen Testing,SARS-CoV-2 Infection Antibody Testing,SARS-CoV-2 Infection Serological Testing,Serology Testing for COVID-19,Antibody Testing, COVID-19,Antibody Testing, COVID19,Antigen Testings, SARS-COV-2,COVID 19 Antibody Testing,COVID 19 Serodiagnosis,COVID 19 Serological Testing,COVID-19 Antibody Testings,COVID-19 Serodiagnoses,COVID-19 Serological Testings,COVID19 Antibody Testings,COVID19 Serodiagnoses,COVID19 Serological Testings,SARS COV 2 Antigen Testing,SARS CoV 2 Infection Antibody Testing,SARS CoV 2 Infection Serological Testing,SARS-COV-2 Antigen Testings,Serodiagnosis, COVID-19,Serodiagnosis, COVID19,Serological Testing, COVID-19,Serological Testing, COVID19,Serology Testing for COVID 19,Testing, COVID-19 Antibody,Testing, COVID-19 Serological,Testing, COVID19 Antibody,Testing, COVID19 Serological,Testing, SARS-COV-2 Antigen

Related Publications

Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2.
January 2023, Open life sciences,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis.
March 2021, medRxiv : the preprint server for health sciences,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Comparison of ACCEL ELISA COVID-19 with Elecsys Anti-SARS-CoV-2 for Screening of COVID-19.
March 2022, Annals of clinical and laboratory science,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Approaches applied to detect SARS-CoV-2 in wastewater and perspectives post-COVID-19.
April 2021, Journal of water process engineering,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
March 2021, The journal of applied laboratory medicine,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
September 2020, The journal of applied laboratory medicine,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
[About population tests to detect anti-SARS-CoV-2 antibodies].
January 2020, Medicina,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic.
March 2023, Infectious diseases and therapy,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Research Response to SARS-CoV-2/COVID-19.
September 2020, Mayo Clinic proceedings,
Ángel Guevara, and Sandra Vivero, and Victoria Nipaz, and Victor Guaraca, and Josefina Coloma
Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
December 2020, International journal of cancer,
Copied contents to your clipboard!